The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.

China-based medical research services provider Yunhu Technology has attracted tens of millions of renminbi (RMB10m = $1.5m) in a series A-plus round involving Cash Capital, an investment arm of Chinese Academy of Sciences. Venture capital firm China Creation Ventures led the round, which was backed by Vision+ Capital, Morningside Venture Capital, and BioTrack Capital. Founded…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.